newsfilter
← Latest News
GlobeNewswire·

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (("Recro", NASDAQ:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily i